Institutional investors purchased a net $12.3 million shares of ALIM during the quarter ended September 2017 and now own 54.93% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PALO ALTO INVESTORS LLC Bought 9.0 Million shares of Alimera Sciences Inc
DEERFIELD MANAGEMENT COMPANY LP Bought 1.3 Million shares of Alimera Sciences Inc
THE VANGUARD GROUP, INC. Bought 468.5 Thousand shares of Alimera Sciences Inc